| Year |
Citation |
Score |
| 2010 |
Kundu S, Fan K, Cao M, Lindner DJ, Tuthill R, Liu L, Gerson S, Borden E, Yi T. Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics. Molecular Cancer Therapeutics. 9: 2287-96. PMID 20682647 DOI: 10.1158/1535-7163.Mct-10-0159 |
0.356 |
|
| 2010 |
Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. Journal of Immunology (Baltimore, Md. : 1950). 184: 6529-36. PMID 20421638 DOI: 10.4049/Jimmunol.0903562 |
0.404 |
|
| 2010 |
Akiyama S, Dhavan D, Yi T. PRL-2 increases Epo and IL-3 responses in hematopoietic cells. Blood Cells, Molecules & Diseases. 44: 209-14. PMID 20226699 DOI: 10.1016/J.Bcmd.2010.02.013 |
0.417 |
|
| 2010 |
Cao M, Lindner D, Borden E, Shalwitz R, Yi T. Abstract 1560: VE-PTP inhibitor AKB-9778 mitigates IL-2-induced VLS and interacts positively with IL-2 against melanoma and renal cancer tumors in mice Cancer Research. 70: 1560-1560. DOI: 10.1158/1538-7445.Am10-1560 |
0.419 |
|
| 2009 |
Fan K, Borden E, Yi T. Interferon-γ is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/Interleukin-2 and mediates its antitumor activity n vivo Journal of Interferon and Cytokine Research. 29: 451-459. PMID 19514839 DOI: 10.1089/Jir.2008.0061 |
0.395 |
|
| 2008 |
Yi T, Lindner D. The role and target potential of protein tyrosine phosphatases in cancer Current Oncology Reports. 10: 114-121. PMID 18377824 DOI: 10.1007/S11912-008-0019-6 |
0.354 |
|
| 2006 |
Hardin AO, Meals EA, Yi T, Knapp KM, English BK. SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages. Biochemical and Biophysical Research Communications. 342: 547-55. PMID 16487932 DOI: 10.1016/J.Bbrc.2006.02.005 |
0.366 |
|
| 2006 |
Yi T, Fan K, Finke J, Bukowski R, Borden EC. Activation of human peripheral blood immune cells in vitro by sodium stibogluconate (SSG) and SSG/IL-2 combination Journal of Clinical Oncology. 24: 2557-2557. DOI: 10.1200/Jco.2006.24.18_Suppl.2557 |
0.409 |
|
| 2005 |
Fan K, Zhou M, Pathak MK, Lindner DJ, Altuntas CZ, Tuohy VK, Borden EC, Yi T. Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages. Journal of Immunology (Baltimore, Md. : 1950). 175: 7003-8. PMID 16272361 DOI: 10.4049/Jimmunol.175.10.7003 |
0.43 |
|
| 2004 |
Sakamoto S, Qin J, Navarro A, Gamero A, Potla R, Yi T, Zhu W, Baker DP, Feldman G, Larner AC. Cells previously desensitized to type 1 interferons display different mechanisms of activation of stat-dependent gene expression from naïve cells. The Journal of Biological Chemistry. 279: 3245-53. PMID 14600148 DOI: 10.1074/Jbc.M309631200 |
0.482 |
|
| 2003 |
Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A, Yi T, Williams BR, Borden EC. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 23: 745-56. PMID 14769151 DOI: 10.1089/107999003772084860 |
0.337 |
|
| 2003 |
Chen Y, Wen R, Yang S, Schuman J, Zhang EE, Yi T, Feng GS, Wang D. Identification of Shp-2 as a Stat5A phosphatase. The Journal of Biological Chemistry. 278: 16520-7. PMID 12615921 DOI: 10.1074/Jbc.M210572200 |
0.409 |
|
| 2002 |
Yi T, Pathak MK, Lindner DJ, Ketterer ME, Farver C, Borden EC. Anticancer activity of sodium stibogluconate in synergy with IFNs. Journal of Immunology (Baltimore, Md. : 1950). 169: 5978-85. PMID 12421984 DOI: 10.4049/Jimmunol.169.10.5978 |
0.434 |
|
| 2002 |
Pathak MK, Hu X, Yi T. Effects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitro Leukemia. 16: 2285-2291. PMID 12399974 DOI: 10.1038/Sj.Leu.2402692 |
0.42 |
|
| 2002 |
Kant AM, De P, Peng X, Yi T, Rawlings DJ, Kim JS, Durden DL. SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC. Blood. 100: 1852-9. PMID 12176909 |
0.449 |
|
| 2002 |
Yang W, Tabrizi M, Yi T. A bipartite NLS at the SHP-1 C-terminus mediates cytokine-induced SHP-1 nuclear localization in cell growth control Blood Cells, Molecules, and Diseases. 28: 63-74. PMID 11987243 DOI: 10.1006/Bcmd.2002.0485 |
0.68 |
|
| 2002 |
Kant AM, De P, Peng X, Yi T, Rawlings DJ, Kim JS, Durden DL. SHP-1 regulates Fcγ receptor–mediated phagocytosis and the activation of RAC Blood. 100: 1852-1859. DOI: 10.1182/BLOOD.V100.5.1852.H81702001852_1852_1859 |
0.442 |
|
| 2001 |
Dong F, Qiu Y, Yi T, Touw IP, Larner AC. The Carboxyl Terminus of the Granulocyte Colony- Stimulating Factor Receptor, Truncated in Patients with Severe Congenital Neutropenia/Acute Myeloid Leukemia, Is Required for SH2-Containing Phosphatase-1 Suppression of Stat Activation Journal of Immunology. 167: 6447-6452. PMID 11714811 DOI: 10.4049/Jimmunol.167.11.6447 |
0.404 |
|
| 2001 |
Pathak MK, Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines Journal of Immunology. 167: 3391-3397. PMID 11544330 DOI: 10.4049/Jimmunol.167.6.3391 |
0.471 |
|
| 2000 |
Ward AC, Oomen SPMA, Smith L, Gits J, Leeuwen DV, Soede-Bobok AA, Erpelinck-Verschueren CAJ, Yi T, Touw IP. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. Leukemia. 14: 1284-1291. PMID 10914554 DOI: 10.1038/Sj.Leu.2401822 |
0.455 |
|
| 2000 |
Wu DW, Stark KC, Dunnington D, Dillon SB, Yi T, Jones C, Pelus LM. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Blood Cells, Molecules & Diseases. 26: 15-24. PMID 10772872 DOI: 10.1006/Bcmd.2000.0273 |
0.421 |
|
| 1999 |
Wickrema A, Uddin S, Sharma A, Chen F, Alsayed Y, Ahmad S, Sawyer ST, Krystal G, Yi T, Nishada K, Hibi M, Hirano T, Platanias LC. Engagement of Gab1 and Gab2 in erythropoietin signaling. The Journal of Biological Chemistry. 274: 24469-74. PMID 10455108 DOI: 10.1074/Jbc.274.35.24469 |
0.501 |
|
| 1999 |
Wickrema A, Chen F, Namin F, Yi T, Ahmad S, Uddin S, Chen YH, Feldman L, Stock W, Hoffman R, Platanias LC. Defective expression of the SHP-1 phosphatase in polycythemia vera. Experimental Hematology. 27: 1124-32. PMID 10390187 DOI: 10.1016/S0301-472X(99)00043-0 |
0.398 |
|
| 1998 |
Haque SJ, Harbor P, Tabrizi M, Yi T, Williams BRG. Protein-tyrosine Phosphatase Shp-1 Is a Negative Regulator of IL-4- and IL-13-dependent Signal Transduction Journal of Biological Chemistry. 273: 33893-33896. PMID 9852037 DOI: 10.1074/Jbc.273.51.33893 |
0.645 |
|
| 1998 |
Binstadt BA, Billadeau DD, Jevremović D, Williams BL, Fang N, Yi T, Koretzky GA, Abraham RT, Leibson PJ. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. The Journal of Biological Chemistry. 273: 27518-23. PMID 9765283 DOI: 10.1074/Jbc.273.42.27518 |
0.469 |
|
| 1998 |
Uddin S, Grumbach IM, Yi T, Colamonici OR, Platanias LC. Interferon alpha activates the tyrosine kinase Lyn in haemopoietic cells. British Journal of Haematology. 101: 446-9. PMID 9633884 DOI: 10.1046/J.1365-2141.1998.00731.X |
0.407 |
|
| 1998 |
Migone TS, Cacalano NA, Taylor N, Yi T, Waldmann TA, Johnston JA. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells Proceedings of the National Academy of Sciences of the United States of America. 95: 3845-3850. PMID 9520455 DOI: 10.1073/Pnas.95.7.3845 |
0.417 |
|
| 1998 |
Tabrizi M, Yang W, Jiao H, Devries EMG, Platanias LC, Arico M, Yi T. Reduced Tyk2/SHP-1 interaction and lack of SHP-1 mutation in a kindred of familial hemophagocytic lymphohistiocytosis. Leukemia. 12: 200-206. PMID 9519782 DOI: 10.1038/Sj.Leu.2400949 |
0.62 |
|
| 1998 |
Platanias LC, Domanski P, Nadeau OW, Yi T, Uddin S, Fish E, Neel BG, Colamonici OR. Identification of a domain in the beta subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs. The Journal of Biological Chemistry. 273: 5577-81. PMID 9488684 DOI: 10.1074/Jbc.273.10.5577 |
0.415 |
|
| 1998 |
Yang W, Tabrizi M, Berrada K, Yi T. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses Blood. 91: 3746-3755. DOI: 10.1182/Blood.V91.10.3746.3746_3746_3755 |
0.635 |
|
| 1997 |
Burshtyn DN, Yang W, Yi T, Long EO. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. The Journal of Biological Chemistry. 272: 13066-72. PMID 9148918 DOI: 10.1074/jbc.272.20.13066 |
0.311 |
|
| 1997 |
Liao Y, Yi T, Hoit BD, Walsh RA, Karnik SS, Husain A. Selective reporter expression in mast cells using a chymase promoter. The Journal of Biological Chemistry. 272: 2969-76. PMID 9006944 DOI: 10.1074/Jbc.272.5.2969 |
0.397 |
|
| 1996 |
Jiao H, Berrada K, Yang W, Tabrizi M, Platanias LC, Yi T. Direct Association With And Dephosphorylation Of Jak2 Kinase By The Sh2-Domain-Containing Protein Tyrosine Phosphatase Shp-1 Molecular and Cellular Biology. 16: 6985-6992. PMID 8943354 DOI: 10.1128/Mcb.16.12.6985 |
0.655 |
|
| 1996 |
Uddin S, Gardziola C, Dangat A, Yi T, Platanias LC. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochemical and Biophysical Research Communications. 225: 833-8. PMID 8780698 DOI: 10.1006/Bbrc.1996.1259 |
0.492 |
|
| 1996 |
Frearson JA, Yi T, Alexander DR. A tyrosine-phosphorylated 110-120-kDa protein associates with the C-terminal SH2 domain of phosphotyrosine phosphatase-1D in T cell receptor-stimulated T cells European Journal of Immunology. 26: 1539-1543. PMID 8766558 DOI: 10.1002/eji.1830260720 |
0.351 |
|
| 1996 |
Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4: 77-85. PMID 8574854 DOI: 10.1016/S1074-7613(00)80300-3 |
0.458 |
|
| 1995 |
Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. The Journal of Biological Chemistry. 270: 18179-82. PMID 7629131 DOI: 10.1074/Jbc.270.31.18179 |
0.506 |
|
| 1995 |
Damen JE, Cutler RL, Jiao H, Yi T, Krystal G. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. The Journal of Biological Chemistry. 270: 23402-8. PMID 7559499 DOI: 10.1074/Jbc.270.40.23402 |
0.48 |
|
| 1995 |
Yi T, Zhang J, Miura O, Ihle J. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites Blood. 85: 87-95. DOI: 10.1182/BLOOD.V85.1.87.BLOODJOURNAL85187 |
0.371 |
|
| 1994 |
Tang B, Mano H, Yi T, Ihle JN. Tec kinase associates with c-kit and is tyrosine phosphorylated and activated following stem cell factor binding Molecular and Cellular Biology. 14: 8432-8437. PMID 7526158 DOI: 10.1128/mcb.14.12.8432-8437.1994 |
0.427 |
|
| 1994 |
Ihle JN, Witthuhn B, Tang B, Yi T, Quelle FW. 2 Cytokine receptors and signal transduction Bailliere's Clinical Haematology. 7: 17-48. PMID 7518712 DOI: 10.1016/S0950-3536(05)80005-8 |
0.362 |
|
| 1994 |
Katzav S, Sutherland M, Packham G, Yi T, Weiss A. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. Journal of Biological Chemistry. 269: 32579-32585. DOI: 10.1016/s0021-9258(18)31673-9 |
0.306 |
|
| 1993 |
Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction Proceedings of the National Academy of Sciences of the United States of America. 90: 8429-8433. PMID 8378315 DOI: 10.1073/Pnas.90.18.8429 |
0.438 |
|
| 1993 |
English BK, Ihle JN, Myracle A, Yi T. Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages Journal of Experimental Medicine. 178: 1017-1022. PMID 8350043 DOI: 10.1084/Jem.178.3.1017 |
0.353 |
|
| 1993 |
Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin Cell. 74: 227-236. PMID 8343951 DOI: 10.1016/0092-8674(93)90414-L |
0.39 |
|
| 1993 |
Yi T, Mui ALF, Krystal G, Ihle JN. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis Molecular and Cellular Biology. 13: 7577-7586. PMID 8246974 DOI: 10.1128/Mcb.13.12.7577 |
0.422 |
|
| 1993 |
Yi T, Ihle JN. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand Molecular and Cellular Biology. 13: 3350-3358. PMID 7684496 DOI: 10.1128/mcb.13.6.3350-3358.1993 |
0.391 |
|
| 1992 |
Yi T, Cleveland JL, Ihle JN. Protein tyrosine phosphatase containing SH2 domains: Characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13 Molecular and Cellular Biology. 12: 836-846. PMID 1732748 DOI: 10.1128/mcb.12.2.836-846.1992 |
0.389 |
|
| 1991 |
Yi T, Bolen JB, Ihle JN. Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus Molecular and Cellular Biology. 11: 2391-2398. PMID 2017160 DOI: 10.1128/Mcb.11.5.2391 |
0.334 |
|
| Show low-probability matches. |